Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
This study is ongoing, but not recruiting participants.
Cheryl Rosenfeld, DO
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Cheryl Rosenfeld, DO, North Jersey Endocrine Consultants, LLC
First received: June 3, 2010
Last updated: October 13, 2011
Last verified: October 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||April 2012|
|Estimated Primary Completion Date:||January 2012 (Final data collection date for primary outcome measure)|